Natural Product Communications · 2014 · 12 citations · 15 references
Nutraceutical IngredientGlycobiologyGlucocorticoidα-Glucosidase InhibitionFlavonoids 3Pharmaceutical ChemistryHypoglycemic EffectMedicinal ChemistryOrthosiphon AristatusPhytochemicalBiochemistryMaltase FunctionAerial PartsPharmacologyAnti-inflammatoryNatural SciencesPhysiologyMetabolismMedicineDrug Discovery
An infusion of Orthosiphon aristatus has long been used for diabetes therapy; however, the active principles remained unknown. Herein, we report the identification of the putative agents responsible for this antidiabetic activity using an a-glucosidase-guided isolation. Four flavonoids named sinensetin (1), salvigenin (2), tetramethylscutellarein (3) and 3,7,4'-tri-O-methylkaempferol (4), together with a diterpenoid named orthosiphol A (5), were characterized, based on analysis of their spectroscopic data. Flavonoids 3 and 4 inhibited yeast a-glucosidase with IC,o values of 6.34 and 0.75 mM, respectively, whereas orthosiphol A (5) selectively inhibited intestinal maltase with an IC5o, value of 6.54 mM. A kinetic investigation of 5 indicated that it retarded maltase function in a noncompetitive manner.
15
Elsnoussi Ali Hussin Mohamed, Jamshed Siddiqui, Lee Fung Ang et al. · BMC Complementary and Alternative Medicine · 2012 · 191 citations · Full text
Arin Wikul, Thanakorn Damsud, Keita Kataoka et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 77 citations · Full text